Granules India Ltd - 532482 - Receipt Of Establishment Inspection Report (EIR) From US FDA
Receipt of Establishment Inspection Report (EIR) from US FDA12-09-2019
12-09-2019
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement confirming dispatchof Postal Ballot Notice.11-09-2019
Granules India Ltd - 532482 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal Ballot09-09-2019
GRANULES INDIA LTD.-$ - 532482 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Granules India Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here30-08-2019
Granules India Ltd - 532482 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 28TH Annual General Meeting30-08-2019
Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release issued by the Company for divestment of its stake in Granules OmniChem Private Limited, a Joint Venture Company located in India29-08-2019
GRANULES INDIA LTD.-$ - 532482 - Outcome of Board Meeting
Outcome 192nd Board Meeting dated 29th August 201929-08-2019
FDA issues observations for Granules India's US arm facility
Drug firm Granules India on Thursday said the US health regulator has issued two observations after inspection of Chantilly facility of its American a22-08-2019
Granules India Ltd - 532482 - Granules Pharmaceuticals, Inc. Completed U.S. FDA Inspection.
Granules Pharmaceuticals, Inc. completed U.S. FDA inspection.22-08-2019
Granules India (97.3): Buy
The stock of Granules India has gained 4 per cent with good volume on Thursday, breaking above an immediate resistance at 93. This rally provides tra09-08-2019